Fierce Pharma

NOVEMBER 29, 2022

Teva-partnered MedinCell bags $42M loan for long-acting injectable R&D. ntaylor. Tue, 11/29/2022 - 10:27.

249

249

Pharmaceutical Technology

NOVEMBER 29, 2022

The National Health Service (NHS) in England, UK, has expedited the rollout of Bayer ’s new life-extending drug, darolutamide, to treat the most advanced kinds of prostate cancer that have spread to other body parts. With the latest development, NHS will become the first healthcare system in Europe to offer this drug to prostate cancer patients. Nearly 9,000 men with prostate cancer will be eligible to receive this treatment.

Healthcare 118

Healthcare Healthcare Patients Medicine 118

Fierce Pharma

NOVEMBER 29, 2022

LTS Lohmann leads investment in needle-free delivery specialist. ntaylor. Tue, 11/29/2022 - 10:21.

Leads 241

Leads 241

MedCity News

NOVEMBER 29, 2022

As gene sequencing, machine learning, powerful imaging, sensors, gene and cell therapies make their way out of academic labs into everyday healthcare, our approach to healthcare is changing. For the first time, not only can we pinpoint the molecular and genetic causes of disease, but we also have the technologies to access them. On the back of this, prevention and cures are becoming possible.

Healthcare 115

Healthcare Healthcare Pharmaceutical Biopharma 115

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Fierce Pharma

NOVEMBER 29, 2022

Roche pulls another FDA accelerated approval for cancer drug Tecentriq. kdunleavy. Tue, 11/29/2022 - 10:22.

FDA 246

FDA 246

MedCity News

NOVEMBER 29, 2022

Nvidia unveiled new tools designed to make it easier for hospitals to integrate AI models related to medical imaging into their clinical workflows. The tools have been adopted by major cloud infrastructure providers, as well as healthcare providers and AI software companies. Some of these include Cincinnati Children’s Hospital, University of California San Francisco, England’s National Health Service and Qure.ai.

Healthcare Provider 114

Healthcare Provider Medical Healthcare Healthcare 114

Pharma IQ

NOVEMBER 29, 2022

Discover why regulatory compliance, an integration strategy and having the right team are vital for successful mergers and acquisitions in the pharma sector.

Pharma 100

Pharma 100

Fierce Pharma

NOVEMBER 29, 2022

Even after Supreme Court snub, Bristol Myers pleads for rehearing in bid to revive $1.2B award. fkansteiner. Tue, 11/29/2022 - 10:18.

130

130

MedCity News

NOVEMBER 29, 2022

We now see the next wave of potential cancer therapies on the horizon, propelled by significant advancements in immunology, as well as an increased understanding of tumor-driven mechanisms of immune evasion.

Biopharma 114

Biopharma 114

Pharmaceutical Technology

NOVEMBER 29, 2022

AstraZeneca has signed an agreement for the acquisition of all outstanding equity of clinical-stage biotechnology firm Neogene Therapeutics in a deal totalling up to $320m. Neogene focuses on discovering, developing and producing next-generation T-cell receptor therapies (TCR-Ts) that provide a new cell therapy approach for fighting cancer. TCR-Ts can detect intracellular targets such as cancer-specific mutations to unlock targets which were not accessible earlier using cell therapies.

Manufacturing 111

Manufacturing Leads Patients Pharmaceutical 111

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

NOVEMBER 29, 2022

If the medical field wants to make serious progress on the Cancer Moonshot effort, it must expand its definition of personalized medicine and explore fresh approaches to cancer prevention, according to Dr. Siddhartha Mukherjee, a Pulitzer Prize-winning author and cancer physician at Columbia University Medical Center.

Physicians 110

Physicians Medicine Medical 110

Pharmaceutical Technology

NOVEMBER 29, 2022

For several decades, researchers have been investigating the role of ketamine in treating depression. Now, efforts are underway to study ketamine’s effects in Parkinson’s disease, fibromyalgia, and Rett syndrome. On November 14, the Canadian developer PharmaTher announced positive data from a Phase I/II study where ketamine was used to treat levodopa-induced dyskinesia in Parkinson’s disease.

Side effects 110

Side effects Pharmaceutical Patients Medicine 110

MedCity News

NOVEMBER 29, 2022

The average monthly premium for Medicare Advantage plans increased to $7 in the first half of the Medicare Annual Open Enrollment period this year, the eHealth report found. Premiums were in the $4 to $5 range for the last three years.

109

109

European Pharmaceutical Review

NOVEMBER 29, 2022

A £2.9 million, UK-wide adaptive platform trial (APT) has been launched to find effective treatments for people hospitalised with severe flu for the first time, testing multiple options simultaneously in thousands of people then modifying treatments quickly. The research aims to find treatments that reduce deaths from flu and prevent patients needing intensive care.

Medicine 101

Medicine Recruitment Consulting Healthcare 101

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

MedCity News

NOVEMBER 29, 2022

The funding round was led by Optum Ventures. Other investors include Adams Street Partners, Blue Shield of California and Humana. DispatchHealth will use the money to expand its capabilities in current markets, its CEO said.

Marketing 110

Marketing 110

PM360

NOVEMBER 29, 2022

When developing content for new drug labels, life sciences companies’ regulatory teams face challenges in gathering intelligence to better understand competitive factors, market dynamics, and effective approval strategies. To overcome these barriers, organizations are increasingly looking to technology such as natural language processing (NLP) to reduce the manual, repetitive steps of acquiring regulatory intelligence.

Food and Drug Administration 98

Food and Drug Administration Competition Safety Pharmacology 98

MedCity News

NOVEMBER 29, 2022

AstraZeneca is jumping into the chase for cell therapies that address solid tumors by acquiring Neogene Therapeutics. The startup’s technology can be used to discover and develop novel targets that may be able to broaden the scope of cell therapies for cancer.

Biopharma 98

Biopharma Pharma 98

PM360

NOVEMBER 29, 2022

The White House’s recent Health Sector Climate Pledge brought together hospitals and healthcare companies that committed to reduce greenhouse gas emissions 50% by 2030. It is a long overdue effort to promote sustainability and combat climate change. The social, economic, and environmental impact of such initiatives are clear, but only a few companies in the healthcare industry have made this kind of commitment so far.

Healthcare 98

Healthcare Healthcare Manufacturing Distribution 98

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Legacy MEDSearch

NOVEMBER 29, 2022

Densitas ® Inc., a global provider of A.I. solutions for digital mammography and breast screening announced that Desert Imaging has implemented the densitas® IntelliMammo platform across their health system. The adoption of intelliMammo reinforces Desert Imaging’s established commitment to maintaining robust organization-wide quality improvement initiatives.

Recruitment 98

Recruitment FDA Engineering Management 98

PM360

NOVEMBER 29, 2022

As healthcare marketers, we often focus on the official launch of a new product as a pinnacle moment for its commercial success. But in many cases, success depends on actions taken before the launch date—specifically, how well the market has been primed to receive a novel product. In addition to all the regulatory hurdles that must be cleared, marketers must also deal with the challenge of getting potential customers to adopt a new category of healthcare products.

Marketing 98

Marketing Healthcare Healthcare Education 98

MedCity News

NOVEMBER 29, 2022

Dr. Akram Boutros said in a lawsuit filed Monday in Cuyahoga County court that Cleveland-based MetroHealth’s board of directors violated open meeting laws when it “secretly hired” counsel to investigate him and then terminated him without mandatory public notice. .

94

94

European Pharmaceutical Review

NOVEMBER 29, 2022

AstraZeneca has announced it will acquire biotech Neogene Therapeutics Inc. for up to $320 million, to boost development of next-generation oncology T-cell receptor therapies (TCR-Ts) for patients with solid tumours, helping to increase access to cell therapies. T-cell receptor therapies. TCR-Ts are an emerging therapeutic to treat cancer. Most current cell therapy approaches for oncology focus on modifying the immune system’s T cells to recognise proteins on the surface of cancer cells.

Manufacturing 93

Manufacturing Leads Medicine Patients 93

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

Pharma Pathway

NOVEMBER 29, 2022

Encube Ethicals- Openings for Officer/ Jr. Engineer in Production Department -Apply Now. Job Description. Greetings from Encube Ethicals Pvt. Ltd !!! Openings for Multiple Positions in Production Department @ Encube Ethicals Pvt. Ltd. Department: Production. Designation: Officer/ Jr. Engineer. Education: B.Pharm/ Diploma. Experience: 01 to 03 years.

Ethics 89

Ethics Engineering Education 89

Integrity Solutions

NOVEMBER 29, 2022

While investing in sales training can produce a range of benefits, all of us in sales know it all boils down to the bottom line. Here are the sales training metrics you should be using to measure your success. Here’s the cold hard truth about sales training ROI: While companies around the world continue to invest billions in sales enablement initiatives every year, most of these organizations cannot trace any tangible improvements in the key metrics that matter to their investment in those

Training 89

Training Sales Sales Management Management 89

European Pharmaceutical Review

NOVEMBER 29, 2022

Patients with metastatic non-small cell lung cancer ( mNSCLC ) with high tumour aneuploidy (tumour cells exhibiting either missing or extra chromosomes) were found to have significantly better survival if radiotherapy (RT) was added to immune checkpoint blockade (ICB) in a Phase I study. The study results, published in Nature Cancer , identified the first biomarker that predicts response to a combination therapy of RT and ICB, suggested that adding radiation to the therapy protocol of patients w

Patients 84

Patients Medicine Pharmaceutical 84

PharmaVoice

NOVEMBER 29, 2022

The biotech is using human skin squares from plastic surgery to find the best immunological molecules for solving conditions like dermatitis.

98

98

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Pharma Pathway

NOVEMBER 29, 2022

Mankind Pharma Limited- Openings for Engineering (Injectable Exposure)- Apply Now. Job Description: HVAC – Engineer @ Mankind Pharma Limited. Department: Engineering (Injectable Exposure). Designation: Exexutive/ Sr.Exexutive. Qualification : Diploma / B. Tech – Electrical (Regular). Experience: 06 to 8 years. Skill Required: 1. Experience in Injectable facility. 2.

Engineering 77

Engineering Pharma 77

PharmaTimes

NOVEMBER 29, 2022

Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA

102

102

Copyright Clearance Center

NOVEMBER 29, 2022

The post Spotlight on Generations Fund Supporter: CCC? appeared first on Copyright Clearance Center.

98

98

PharmaTimes

NOVEMBER 29, 2022

Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial cancer

95

95

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients